5V8-32822-17917 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-16
Dose 1 — Pfizer-BioNTech
2021-05-07
Dose 2 — Pfizer-BioNTech
2022-01-29
Registered in v-safe
2022-01-29
Dose 3 — Pfizer-BioNTech
2022-01-29
Health check-in — day 0, dose 3
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2022-01-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-01-31
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain — Feeling: Good · Fatigue or tiredness

Free text: Sore left armpit

MedDRA releases: 2024-11 · check-in free text available
2022-02-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-02-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Fatigue or tiredness

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-16	Pfizer-BioNTech	No
2	2021-05-07	Pfizer-BioNTech	No
3	2022-01-29	Pfizer-BioNTech	No

Free text

Release 11 — days 1–6 daily, dose 3

2022-01-31

Systemic reaction (other): Sore left armpit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Axillary pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release